Lv7
5005 积分 2020-03-31 加入
MYD88 L265P mutation and interleukin‐10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study
25天前
已完结
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
1个月前
已完结
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi
2个月前
已完结
Phase 1 trial of HS006, a recombinant human-mouse chimeric anti-CD20 monoclonal antibody to treat CD20 positive B-cell non-Hodgkin's lymphoma in China
3个月前
已关闭
Criteria2Query 3.0: Leveraging generative large language models for clinical trial eligibility query generation
4个月前
已完结
First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma
4个月前
已完结
Fine Epitope Mapping of the CD19 Extracellular Domain Promotes Design
6个月前
已完结
Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission
6个月前
已完结
Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission
6个月前
已关闭
How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B‐cell lymphoma?
6个月前
已完结
皖公网安备34019202002308
